Home -> Law Blog Directory -> Patent Law Blogs -> IPBiz
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: IPBizComments due on paperwork burden of Appeal Rule by 9 Aug 2008
By Lawrence B. Ebert, Esq.
The Patent Office recently published a Federal Register notice that is not publicized on any of the PTO's lists of Federal Register Notices. This continues the trend, now about two years old, of the Patent Office minimizing public participation in various intra-executive branch rulemaking oversight reviews by failing to give prominent notice of the opportunity for public comment.
IPBiz was not impressed by one of the earlier OMB analyses on proposed burdens. IPBiz does find the coverage of the Boundy information by OTHER blogs of some interest:
Patently-O noted: The PTO is asking whether these numbers are accurate under the newly finalized Appeal Brief rules. (This will impact whether the Whitehouse allows the new rules to be implemented). Comments are due by August 9, 2008, to Susan Fawcett (Susan.Fawcett@uspto.gov), who will in turn be required to provide them to OMB. (...) (For some unknown reason, the USPTO did not post information about this request for information from the public).
The coverage at the Patent Hawk blog began:
A recently published UPSTO Federal Register Notice regarding paperwork burdens for the proposed appeals rule change is oddly missing from all PTO lists of Federal Register Notices. The wafting scent is that this is something more than oversight, instead, a continuation of a two-year trend of failing to give sufficient notice of opportunity for public comment.
Full post as published by IPBiz on July 20, 2008 (boomark / email).
Copyright Lawsuits: Critical Issues Before Filing Copyright
Federa Rule 11(b) Considerations
Transportation Equity Act for the 21st Century
TEA-21 - Plus Law 105-178
Philip Morris
Loses Appeal, Will Pay Millions
Asbestos Mesothelioma Victim Wins Appeal of $20 Million Asbestos Cancer Verdict
Asbestos Mesothelioma Victim Wins Appeal of $20 Million Asbestos Cancer Verdict
Cipro
The FDA is seeking to add black box warnings of the risk of tendon rupture associated with Cipro and Levaquin.
The ruptures can involve Achilles tendon, shoulder, hand, bicep or thumb tendons, and is especially increased in patients older than 60, or people who have received kidney, heart or lung transplants, as well as people on steroid therapy...

Trouble Ahead for the USPTO's Appeal Brief Rules
Form 4473 under Paperwork Reduction Act review
The New E-Discovery Financial Burden - The New Rules in Action
COA Dismisses Appeal For Rule Violations
More on the One-Witness Rule Trick Question in Jury Selection
Why I oppose the HHS conscience rule









